Introduction

Fever and pain are among the most common reasons for pediatric consultations. Conditions such as viral fever, upper respiratory tract infections, teething, post-vaccination fever, ear infections, sore throat, and musculoskeletal pain often cause discomfort, irritability, and reduced activity in children.

MEFIRA Suspension is a dual-action analgesic and antipyretic formulation containing Mefenamic Acid and Paracetamol. The combination provides effective relief from fever, pain, and inflammation while improving comfort and helping children return to normal daily activities.

Category:

Description

MEFIRA Suspension is a pediatric oral suspension formulated with Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), and Paracetamol, a well-established analgesic and antipyretic. The combination offers rapid and sustained relief from fever, mild-to-moderate pain, and inflammatory conditions commonly encountered in pediatric practice.

Composition

Each 5 ml contains:

  • Mefenamic Acid IP50 mg
  • Paracetamol IP125 mg
  • Flavoured Syrup Base – q.s.

(Refer to the approved product carton/package insert for complete prescribing information.)

Indications

MEFIRA Suspension is indicated for the symptomatic treatment of:

  • Fever
  • Viral fever
  • Post-vaccination fever
  • Teething pain
  • Toothache
  • Ear pain (Otalgia)
  • Sore throat
  • Headache
  • Musculoskeletal pain
  • Body aches
  • Mild to moderate inflammatory pain
  • Pain associated with upper respiratory tract infections

Mode of Action

Mefenamic Acid

  • Inhibits Cyclooxygenase (COX-1 & COX-2) enzymes.
  • Reduces prostaglandin synthesis responsible for pain, inflammation, and fever.
  • Provides analgesic, anti-inflammatory, and antipyretic effects.

Paracetamol

  • Acts centrally to inhibit prostaglandin synthesis.
  • Effectively reduces fever by acting on the hypothalamic temperature-regulating center.
  • Provides analgesic action for mild to moderate pain.

Combined Action

Together, Mefenamic Acid and Paracetamol provide:

  • Rapid fever reduction
  • Effective pain relief
  • Reduction of inflammation
  • Longer duration of symptom control
  • Improved comfort and faster recovery

Dosage

  • Age Group Recommended Dose
    2–5 Years 5 mL (1 teaspoonful)
    6–12 Years 10 mL (2 teaspoonfuls)
    Above 12 Years 15 mL (3 teaspoonfuls)
  • Shake well before use.
  • Administer using the provided measuring cup or measuring spoon.
  • Do not exceed the recommended dosage.

Clinical Benefits

  • Provides rapid relief from fever.
  • Offers effective relief from mild to moderate pain.
  • Reduces inflammation associated with painful conditions.
  • Helpful in teething pain and post-vaccination fever.
  • Improves comfort during viral illnesses.
  • Provides longer-lasting analgesic action through combination therapy.
  • Well accepted by children due to its pleasant Mango Flavour.
  • Supports faster recovery by reducing discomfort and improving activity levels.

Administration

  • For oral use only.
  • Shake the bottle well before each use.
  • Measure the prescribed dose accurately using the supplied measuring cup or spoon.
  • Preferably administer after meals to minimize gastric discomfort.
  • Store below 30°C in a cool, dry place.
  • Protect from direct sunlight and moisture.
  • Keep the bottle tightly closed after use.
  • Keep out of reach of children.

Reviews

There are no reviews yet.

Be the first to review “Mefira™”

Your email address will not be published. Required fields are marked *